Bod Australia Ltd (AU:BOD) has released an update.
Bod Australia Ltd, a cannabis-focused drug development firm, has signed a Heads of Agreement with Biortica for a backdoor listing after receiving creditor approval and has also secured an R&D tax incentive. The company reported a minor net cash inflow from operating activities and a decrease in customer receipts compared to the previous quarter. These developments occur as Bod Australia Ltd works to finalize a share purchase agreement with Biortica’s shareholders and meet ASX re-listing requirements.
For further insights into AU:BOD stock, check out TipRanks’ Stock Analysis page.
